Roles of the WHHL rabbit in translational research on hypercholesterolemia and cardiovascular diseases

Journal of Biomedicine and Biotechnology

Volumn 2011, Issue , 2011, Pages

  Shiomi, Masashi ^a,b   Kobayashi, Tsutomu ^a   Ito, Takashi ^a  

^a KOBE UNIVERSITY   (Japan)

^b KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ALPHA TOCOPHEROL; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; APOLIPOPROTEIN E; ASCORBIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CHOLESTEROL ACYLTRANSFERASE INHIBITOR; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRIC ACID DERIVATIVE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPOCHOLESTEROLEMIC AGENT; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; OMEGA 3 FATTY ACID; PROBUCOL;

ANION EXCHANGE; ATHEROSCLEROSIS; DRUG MEGADOSE; EXPERIMENTAL MODEL; GENE THERAPY; HEART INFARCTION; HUMAN; HYPERCHOLESTEROLEMIA; LIPOPROTEIN METABOLISM; NONHUMAN; RABBIT; REVIEW; SPECIES DIFFERENCE; TRANSLATIONAL RESEARCH; ANIMAL; CARDIOVASCULAR DISEASE; DISEASE MODEL; LIPID METABOLISM; PATHOLOGY;

ANIMALIA; MUS; ORYCTOLAGUS CUNICULUS; RATTUS;

ANIMALS; CARDIOVASCULAR DISEASES; DISEASE MODELS, ANIMAL; HYPERCHOLESTEROLEMIA; LIPID METABOLISM; RABBITS; SPECIES SPECIFICITY; TRANSLATIONAL RESEARCH;

EID: 79959365076     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2011/406473     Document Type: Review

References (81)

1. World Health Organization, The World Health Report 2002Reducing Risks, Promoting Healthy Life: Statistical Annex 2002 Geneva, Switzerland World Health Organization
2. Teramoto T., Sasaki J., Ueshima H., Egusa G., Kinoshita M., Shimamoto K., Daida H., Biro S., Hirobe K., Funahashi T., Yokote K., Yokode M., Executive summary of Japan Atherosclerosis Society (JAS) guideline for diagnosis and prevention of atherosclerotic cardiovascular diseases for Japanese Journal of Atherosclerosis and Thrombosis 2007 14 2 45 50
3. Yusuf S., Anand S., Cost of prevention: the case of lipid lowering Circulation 1996 93 10 1774 1776 (Pubitemid 26154024)
4. Endo A., Kuroda M., Tsujita Y., ML 236A, ML 236B, and ML 236C, new inhibitors of cholesterogenesis produced by Penicillium citrinum Journal of Antibiotics 1976 29 12 1346 1348 (Pubitemid 8018023)
5. Tsujita Y., Kuroda M., Shimada Y., CS-514, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase: tissue-selective inhibition of sterol synthesis and hypolipidemic effect on various animal species Biochimica et Biophysica Acta 1986 877 1 50 60 (Pubitemid 16060192)
6. Watanabe Y., Studies on characteristic of spontaneously hyperlipidemic rabbit and development of the strain with such property Bulletin of Azabu Veterinary College 1977 2 1 99 124
7. Liew T. V., Ray K. K., Intensive statin therapy in acute coronary syndromes Current Atherosclerosis Reports 2008 10 2 158 163 (Pubitemid 351486151)
8. Shiomi M., Ito T., The Watanabe heritable hyperlipidemic (WHHL) rabbit, its characteristics and history of development: a tribute to the late Dr. Yoshio Watanabe Atherosclerosis 2009 207 1 1 7
9. Watanabe Y., Ito T., Kondo T., Breeding of a rabbit strain of hyperlipidemia and characteristic of these strain Experimental Animals 1977 26 1 35 42 (Pubitemid 8044847)
10. Watanabe Y., Serial inbreeding of rabbits with hereditary hyperlipidemia (WHHL-rabbit). Incidence and development of atherosclerosis and xanthoma Atherosclerosis 1980 36 2 261 268 (Pubitemid 10110021)
11. Tanzawa K., Shimada Y., Kuroda M., WHHL-rabbit: a low density lipoprotein receptor-deficient animal model for familial hypercholesterolemia FEBS Letters 1980 118 1 81 84 (Pubitemid 11245469)
12. Havel R. J., Kita T., Kotite L., Concentration and composition of lipoproteins in blood plasma of the WHHL rabbit. An animal model of human familial hypercholesterolemia Arteriosclerosis 1982 2 6 467 474 (Pubitemid 13193751)
13. Kita T., Brown M., Bilheimer D. W., Goldstein J. L., Delayed clearance of very low density and intermediate density lipoprotein with enhanced conversion to low density lipoprotein in WHHL rabbits Proceedings of the National Academy of Sciences of the United States of America 1982 79 18 5693 5697 (Pubitemid 13252802)
14. Kita T., Goldstein J. L., Brown M. S., Hepatic uptake chylomicron remnants in WHHL rabbits: a mechanism genetically distinct from the low density lipoprotein receptor Proceedings of the National Academy of Sciences of the United States of America 1982 79 11 3623 3627 (Pubitemid 12014522)
15. Dietschy J. M., Kita T., Suckling K. E., Cholesterol synthesis in vivo and in vitro in the WHHL rabbit, an animal with defective low density lipoprotein receptors Journal of Lipid Research 1983 24 4 469 480 (Pubitemid 13094292)
16. Watanabe Y., Ito T., Shiomi M., The effect of selective breeding on the development of coronary atherosclerosis in WHHL rabbits. An animal model for familial hypercholesterolemia Atherosclerosis 1985 56 1 71 79 (Pubitemid 15049650)
17. Shiomi M., Ito T., Shiraishi M., Watanabe Y., Inheritability of atherosclerosis and the role of lipoproteins as risk factors in the development of atherosclerosis in WHHL rabbits: risk factors related to coronary atherosclerosis are different from those related to aortic atherosclerosis Atherosclerosis 1992 96 1 43 52
18. Shiomi M., Ito T., Yamada S., Kawashima S., Fan J., Development of an animal model for spontaneous myocardial infarction (WHHLMI rabbit) Arteriosclerosis, Thrombosis, and Vascular Biology 2003 23 7 1239 1244 (Pubitemid 36871279)
19. Shiomi M., Fan J., Unstable coronary plaques and cardiac events in myocardial infarction-prone Watanabe heritable hyperlipidemic rabbits: questions and quandaries Current Opinion in Lipidology 2008 19 6 631 636
20. Shiomi M., Ito T., Tsukada T., Yata T., Ueda M., Cell compositions of coronary and aortic atherosclerotic lesions in WHHL rabbits differ: an immunohistochemical study Arteriosclerosis and Thrombosis 1994 14 6 931 937
21. Shiomi M., Ito T., Fujioka T., Tsujita Y., Age-associated decrease in plasma cholesterol and changes in cholesterol metabolism in homozygous Watanabe heritable hyperlipidemic rabbits Metabolism 2000 49 4 552 556 (Pubitemid 30196587)
22. Ito T., Yamada S., Shiomi M., Progression of coronary atherosclerosis relates to the onset myocardial infarction in an animal model of spontaneous myocardial infarction (WHHLMI rabbits) Experimental Animals 2004 53 4 339 346 (Pubitemid 41349901)
23. Mowri H. O., Ohkuma S., Takano T., Monoclonal DLR1a/104G antibody recognizing peroxidized lipoproteins in atherosclerotic lesions Biochimica et Biophysica Acta 1988 963 2 208 214 (Pubitemid 18266692)
24. Boyd H. C., Gown A. M., Wolfbauer G., Chait A., Direct evidence for a protein recognized by a monoclonal antibody against oxidatively modified LDL in atherosclerotic lesions from a Watanabe heritable hyperlipidemic rabbit American Journal of Pathology 1989 135 5 815 825 (Pubitemid 20009491)
25. Kita T., Nagano Y., Yokode M., Ishii K., Kume N., Ooshima A., Yoshida H., Kawai C., Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia Proceedings of the National Academy of Sciences of the United States of America 1987 84 16 5928 5931
26. Carew T. E., Schwenke D. C., Steinberg D., Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit Proceedings of the National Academy of Sciences of the United States of America 1987 84 21 7725 7729 (Pubitemid 18035729)
27. Cybulsky M. I., Gimbrone M. A. Jr., Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis Science 1991 251 4995 788 791
28. Buja L. M., Kuta T., Goldstein J. L., Cellular pathology of progressive atherosclerosis in the WHHL rabbit. An animal model of familial hypercholesterolemia Arteriosclerosis 1983 3 1 87 101 (Pubitemid 13083095)
29. Rosenfeld M. E., Tsukada T., Gown A. M., Ross R., Fatty streak initiation in Watanabe Heritable Hyperlipemic and comparably hypercholesterolemic fat-fed rabbits Arteriosclerosis 1987 7 1 9 23 (Pubitemid 17014538)
30. Rosenfeld M. E., Tsukada T., Chait A., Bierman E. L., Gown A. M., Ross R., Fatty streak expansion and maturation in Watanabe heritable hyperlipidemic and comparably hypercholesterolemic fat-fed rabbits Arteriosclerosis 1987 7 1 24 34 (Pubitemid 17014539)
31. Takano T., Amanuma K., Kimura J., Kanaseki T., Ohkuma S., Involvement of macrophages in accumulation and elimination of cholesterol ester in atherosclerotic aorta Acta Histochemica et Cytochemica 1986 19 1 135 143
32. Tsukada T., Rosenfeld M., Ross R., Gown A. M., Immunocytochemical analysis of cellular components in atherosclerotic lesions. Use of monoclonal antibodies with the Watanabe and fat-fed rabbit Arteriosclerosis 1986 6 6 601 613 (Pubitemid 17190161)
33. Kozarsky K. F., Bonen D. K., Giannoni F., Funahashi T., Wilson J. M., Davidson N. O., Hepatic expression of the catalytic subunit of the apolipoprotein B mRNA editing enzyme (apobec-1) ameliorates hypercholesterolemia in LDL receptor-deficient rabbits Human Gene Therapy 1996 7 8 943 957 (Pubitemid 26169659)
34. Nakamuta M., Taniguchi S., Ishida B. Y., Kobayashi K., Chan L., Phenotype interaction of apobec-1 and CETP, LDLR, and ApoE gene expression in mice: role of ApoB mRNA editing in lipoprotein phenotype expression Arteriosclerosis, Thrombosis, and Vascular Biology 1998 18 5 747 755 (Pubitemid 28267654)
35. Perret B., Mabile L., Martinez L., Terc F., Barbaras R., Collet X., Hepatic lipase: structure/function relationship, synthesis, and regulation Journal of Lipid Research 2002 43 8 1163 1169 (Pubitemid 34988164)
36. Agellon L. B., Walsh A., Hayek T., Moulin P., Jiang X. C., Shelanski S. A., Breslow J. L., Tall A. R., Reduced high density lipoprotein cholesterol in human cholesteryl ester transfer protein transgenic mice The Journal of Biological Chemistry 1991 266 17 10796 10801 (Pubitemid 21906874)
37. Watanabe Y., Ito T., Saeki M., Hypolipidemic effects of CS-500 (ML-236B) in WHHL-rabbit, a heritable animal model for hyperlipidemia Atherosclerosis 1981 38 1-2 27 31 (Pubitemid 11138603)
38. Shiomi M., Ito T., Pravastatin sodium, a competitive inhibitor of hepatic 3-hydroxy-3- methylglutaryl coenzyme a reductase, decreases the cholesterol content of newly secreted very-low-density lipoprotein in Watanabe heritable hyperlipidemic rabbits Metabolism 1994 43 5 559 564 (Pubitemid 24145461)
39. Kuroda M., Matsumoto A., Itakura H., Watanabe Y., Ito T., Shiomi M., Fukushige J., Nara F., Fukami M., Tsujita Y., Effects of pravastatin sodium alone and in combination with cholestyramine on hepatic, intestinal and adrenal low density lipoprotein receptors in homozygous Watanabe heritable hyperlipidemic rabbits Japanese Journal of Pharmacology 1992 59 1 65 70
40. Shiomi M., Ito T., Watanabe Y., Tsujita Y., Kuroda M., Arai M., Fukami M., Fukushige J., Tamura A., Suppression of established atherosclerosis and xanthomas in mature WHHL rabbits by keeping their serum cholesterol levels extremely low. Effect of pravastatin sodium in combination with cholestyramine Atherosclerosis 1990 83 1 69 80 (Pubitemid 20210747)
41. Watanabe Y., Ito T., Shiomi M., Tsujita Y., Kuroda M., Arai M., Fukami M., Tamura A., Preventive effect of pravastatin sodium, a potent inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, on coronary atherosclerosis and xanthoma in WHHL rabbits Biochimica et Biophysica Acta 1988 960 3 294 302
42. Shiomi M., Ito T., Tsukada T., Yata T., Watanabe Y., Tsujita Y., Fukami M., Fukushige J. I., Hosokawa T., Tamura A., Reduction of serum cholesterol levels alters lesional composition of atherosclerotic plaques: effect of pravastatin sodium on atherosclerosis in mature WHHL rabbits Arteriosclerosis, Thrombosis, and Vascular Biology 1995 15 11 1938 1944
43. Shiomi M., Ito T., Effect of cerivastatin sodium, a new inhibitor of HMG-CoA reductase, on plasma lipid levels, progression of atherosclerosis, and the lesional composition in the plaques of WHHL rabbits British Journal of Pharmacology 1999 126 4 961 968 (Pubitemid 29103712)
44. Shiomi M., Ito T., Hirouchi Y., Enomoto M., Fibromuscular cap composition is important for the stability of established atherosclerotic plaques in mature WHHL rabbits treated with statins Atherosclerosis 2001 157 1 75 84 (Pubitemid 32539356)
45. Shiomi M., Yamada S., Ito T., Atheroma stabilizing effects of simvastatin due to depression of macrophages or lipid accumulation in the atheromatous plaques of coronary plaque-prone WHHL rabbits Atherosclerosis 2005 178 2 287 294 (Pubitemid 40193442)
46. Otake H., Shite J., Shinke T., Watanabe S., Tanino Y., Ogasawara D., Sawada T., Hirata K. I., Yokoyama M., Relation between plasma adiponectin, high-sensitivity C-reactive protein, and coronary plaque components in patients with acute coronary syndrome American Journal of Cardiology 2008 101 1 1 7 (Pubitemid 350297191)
47. Pepys M. B., Baltz M., Gomer K., Serum amyloid P-component is an acute-phase reactant in the mouse Nature 1979 278 5701 259 261 (Pubitemid 9129075)
48. Fan J., Watanabe T., Transgenic rabbits as therapeutic protein bioreactors and human disease models Pharmacology and Therapeutics 2003 99 3 261 282 (Pubitemid 37311195)
49. Liu G., Iden J. B., Kovithavongs K., Gulamhusein R., Duff H. J., Kavanagh K. M., In vivo temporal and spatial distribution of depolarization and repolarization and the illusive murine T wave Journal of Physiology 2004 555 1 267 279 (Pubitemid 38313076)
50. London B., Cardiac arrhythmias: from (transgenic) mice to men Journal of Cardiovascular Electrophysiology 2001 12 9 1089 1091 (Pubitemid 32846508)
51. Ness G. C., Zhao Z., Keller R. K., Effect of squalene synthase inhibition on the expression of hepatic cholesterol biosynthetic enzymes, LDL receptor, and cholesterol 7 hydroxylase Archives of Biochemistry and Biophysics 1994 311 2 277 285
52. Schneider W. J., Brown M. S., Goldstein J. L., Kinetic defects in the processing of the low density lipoprotein receptor in fibroblasts from WHHL rabbits and a family with familial hypercholesterolemia Molecular Biology Medicine 1983 1 3 353 367
53. Subbiah M. T. R., Yunker R. L., Rymaszewski Z., Kottke B. A., Bale L. K., Cholestyramine treatment in early life of low-density lipoprotein receptor deficient Watanabe rabbits: decreased aortic cholesteryl ester accumulation and atherosclerosis in adult life Biochimica et Biophysica Acta 1987 920 3 251 258 (Pubitemid 17142898)
54. Shiomi M., Ito T., MTP inhibitor decreases plasma cholesterol levels in LDL receptor-deficient WHHL rabbits by lowering the VLDL secretion European Journal of Pharmacology 2001 431 1 127 131 (Pubitemid 33082160)
55. van Boven A. J., Jukema J. W., Zwinderman A. H., Crijns H. J.G. M., Lie K. I., Bruschke A. V. G., Reduction of transient myocardial ischemia with pravastatin in addition to the conventional treatment in patients with angina pectoris Circulation 1996 94 7 1503 1505 (Pubitemid 26320250)
56. Shiomi M., Yamada S., Amano Y., Nishimoto T., Ito T., Lapaquistat acetate, a squalene synthase inhibitor, changes macrophage/lipid-rich coronary plaques of hypercholesterolaemic rabbits into fibrous lesions British Journal of Pharmacology 2008 154 5 949 957 (Pubitemid 351915051)
57. Mortensen A., Hansen B. F., Hansen J. F., Frandsen H., Bartnikowska E., Andersen P. S., Berteisen L. S., Comparison of the effects of fish oil and olive oil on blood lipids and aortic atherosclerosis in Watanabe heritable hyperlipidaemic rabbits British Journal of Nutrition 1998 80 6 565 573 (Pubitemid 29060538)
58. Lichtenstein A. H., Chobanian A. V., Effect of fish oil on atherogenesis in Watanabe heritable hyperlipidemic rats Arteriosclerosis 1990 10 4 597 606 (Pubitemid 20220584)
59. Pfister S. L., Rosolowsky M., Schmitz J. M., Clubb F. J., Campbell W. B., Eicosapentaenoic acid alters vascular reactivity and platelet adhesion in Watanabe heritable hyperlipidemic rabbits European Journal of Pharmacology 1989 161 1 85 89 (Pubitemid 19058851)
60. Rich S., Miller J. F., Charous S., Davis H. R., Shanks P., Glagov S., Lands W. E. M., Development of atherosclerosis in genetically hyperlipidemic rabbits during chronic fish-oil ingestion Arteriosclerosis 1989 9 2 189 194 (Pubitemid 19092101)
61. Clubb F. J., Schmitz J. M., Butler M. M., Buja L. M., Willerson J. T., Campbell W. B., Effect of dietary omega-3 fatty acid on serum lipids, platelet function, and atherosclerosis in Watanabe Heritable Hyperlipidemic rabbits Arteriosclerosis 1989 9 4 529 537 (Pubitemid 19184487)
62. Kita T., Nagano Y., Yokode M., Ishii K., Kume N., Ooshima A., Yoshida H., Kawai C., Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia Proceedings of the National Academy of Sciences of the United States of America 1987 84 16 5928 5931
63. Carew T. E., Schwenke D. C., Steinberg D., Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit Proceedings of the National Academy of Sciences of the United States of America 1987 84 21 7725 7729 (Pubitemid 18035729)
64. de Nigris F., Youssef T., Ciafr S., Franconi F., Anania V., Condorelli G., Palinski W., Napoli C., Evidence for oxidative activation of c-Myc-dependent nuclear signaling in human coronary smooth muscle cells and in early lesions of Watanabe heritable hyperlipidemic rabbits: protective effects of vitamin E Circulation 2000 102 17 2111 2117
65. Yoshida N., Murase H., Kunieda T., Toyokuni S., Tanaka T., Terao J., Naito Y., Tanigawa T., Yoshikawa T., Inhibitory effect of a novel water-soluble vitamin E derivative on atherosclerosis in rabbits Atherosclerosis 2002 162 1 111 117 (Pubitemid 34327348)
66. Yamada N., Ishibashi S., Shimano H., Inaba T., Gotoda T., Harada K., Shimada M., Shiomi M., Watanabe Y., Kawakami M., Yazaki Y., Takaku F., Role of monocyte colony-stimulating factor in foam cell generation Proceedings of the Society for Experimental Biology and Medicine 1992 200 2 240 244
67. Shindo J., Ishibashi T., Yokoyama K., Nakazato K., Ohwada T., Shiomi M., Maruyama Y., Granulocyte-macrophage colony-stimulating factor prevents the progression of atherosclerosis via changes in the cellular and extracellular composition of atherosclerotic lesions in Watanabe heritable hyperlipidemic rabbits Circulation 1999 99 16 2150 2156 (Pubitemid 29196800)
68. Chobanian A. V., Haudenschild C. C., Nickerson C., Hope S., Trandolapril inhibits atherosclerosis in the Watanabe heritable hyperlipidemic rabbit Hypertension 1992 20 4 473 477
69. Hope S., Brecher P., Chobanian A. V., Comparison of the effects of AT receptor blockade and angiotensin converting enzyme inhibition on atherosclerosis American Journal of Hypertension 1999 12 1 I 28 34 (Pubitemid 29118226)
70. Koike H., New pharmacologic aspects of CS-866, the newest angiotensin II receptor antagonist American Journal of Cardiology 2001 87 8, supplement 1 33c 36c (Pubitemid 32385760)
71. Imanishi T., Kuroi A., Ikejima H., Kobayashi K., Muragaki Y., Mochizuki S., Goto M., Yoshida K., Akasaka T., Effects of angiotensin converting enzyme inhibitor and angiotensin II receptor antagonist combination on nitric oxide bioavailability and atherosclerotic change in Watanabe heritable hyperlipidemic rabbits Hypertension Research 2008 31 3 575 584 (Pubitemid 351605849)
72. Imanishi T., Tsujioka H., Ikejima H., Kuroi A., Takarada S., Kitabata H., Tanimoto T., Muragaki Y., Mochizuki S., Goto M., Yoshida K., Akasaka T., Renin inhibitor aliskiren improves impaired nitric oxide bioavailability and protects against atherosclerotic changes Hypertension 2008 52 3 563 572
73. van Niekerk J. L. M., Hendriks Th., de Boer H. H. M., Van 't Laar A., Does nifedipine suppress atherogenesis in WHHL rabbits? Atherosclerosis 1984 53 1 91 98 (Pubitemid 14041917)
74. Chobanian A. V., The effects of ACE inhibitors and other antihypertensive drugs on cardiovascular risk factors and atherogenesis Clinical Cardiology 1990 13 6 VII43 VII48
75. Hosomi H., Katsuda S., Watanabe Y., Effect of atherosclerosis on the responsiveness of the rapidly acting arterial pressure control system in WHHL rabbits Cardiovascular Research 1986 20 3 195 200 (Pubitemid 16133645)
76. Sata M., Fukuda D., Crucial role of renin-angiotensin system in the pathogenesis of atherosclerosis Journal of Medical Investigation 2010 57 1-2 12 25
77. Ogawa M., Ishino S., Mukai T., Asano D., Teramoto N., Watabe H., Kudomi N., Shiomi M., Magata Y., Iida H., Saji H., F-FDG accumulation in atherosclerotic plaques: immunohistochemical and PET imaging study Journal of Nuclear Medicine 2004 45 7 1245 1250 (Pubitemid 47611672)
78. Meding J., Urich M., Licha K., Reinhardt M., Misselwitz B., Fayad Z. A., Weinmann H. J., Magnetic resonance imaging of atherosclerosis by targeting extracellular matrix deposition with Gadofluorine M Contrast Media Molecular Imaging 2007 2 3 120 129 (Pubitemid 47180344)
79. Steen H., Lima J. A. C., Chatterjee S., Kolmakova A., Gao F., Rodriguez E. R., Stuber M., High-resolution three-dimensional aortic magnetic resonance angiography and quantitative vessel wall characterization of different atherosclerotic stages in a rabbit model Investigative Radiology 2007 42 9 614 621 (Pubitemid 47262929)
80. Iwata A., Miura S. I., Imaizumi S., Zhang B., Saku K., Measurement of atherosclerotic plaque volume in hyperlipidemic rabbit aorta by intravascular ultrasound Journal of Cardiology 2007 50 4 229 234 (Pubitemid 351699942)
81. Ogawa M., Magata Y., Kato T., Hatano K., Ishino S., Mukai T., Shiomi M., Ito K., Saji H., Application of F-FDG PET for monitoring the therapeutic effect of antiinflammatory drugs on stabilization of vulnerable atherosclerotic plaques Journal of Nuclear Medicine 2006 47 11 1845 1850 (Pubitemid 47545007)